A Canadian healthcare company successfully completed a major stock market debut Tuesday, with Apotex Health setting the price for its initial public offering at the maximum end of its projected range.
The company established its share price at C$24 each, generating approximately C$1.3 billion in total proceeds, equivalent to roughly $931.90 million in U.S. currency.
According to company officials, Apotex Health distributed 54.17 million common shares through the expanded offering. Trading is scheduled to commence Wednesday on the Toronto Stock Exchange, where shares will be available under the ticker symbol “APTX”.
The successful IPO represents one of the larger healthcare sector public offerings in the Canadian market this year, with the company achieving its maximum fundraising target.
